These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 5012456)

  • 1. Anomeric structure of ceramide digalactoside isolated from the kidney of a patient with Fabry's disease.
    Li YT; Li SC; Dawson G
    Biochim Biophys Acta; 1972 Jan; 260(1):88-92. PubMed ID: 5012456
    [No Abstract]   [Full Text] [Related]  

  • 2. [Urinary glycolipids in Fabry's disease].
    Gregoire PE; Jonniaux G; Voet W
    Clin Chim Acta; 1971 Jul; 33(2):387-94. PubMed ID: 5119314
    [No Abstract]   [Full Text] [Related]  

  • 3. Anomeric configuration of galactose residues in ceramide trihexosides.
    Li YT; Li SC
    J Biol Chem; 1971 Jun; 246(11):3769-71. PubMed ID: 5104445
    [No Abstract]   [Full Text] [Related]  

  • 4. Fabry's disease as an -galactosidosis: evidence for an -configuration in trihexosyl ceramide.
    Bensaude I; Callahan J; Philippart M
    Biochem Biophys Res Commun; 1971 May; 43(4):913-8. PubMed ID: 5563756
    [No Abstract]   [Full Text] [Related]  

  • 5. Presence of alpha-anomeric glycosidic configuration in the glycolipids accumulated in kidney with Fabry's disease.
    Handa S; Ariga T; Miyatake T; Yamakawa T
    J Biochem; 1971 Mar; 69(3):625-7. PubMed ID: 5551655
    [No Abstract]   [Full Text] [Related]  

  • 6. Enzyme transplantation in Fabry's disease.
    Krivit W; Desnick RJ; Bernlohr RW; Wold F; Najarian JS; Simmons RL
    N Engl J Med; 1972 Dec; 287(24):1248-9. PubMed ID: 4563680
    [No Abstract]   [Full Text] [Related]  

  • 7. Enzyme replacement therapy by renal allotransplantation in Fabry's disease.
    Clarke JT; Guttmann RD; Wolfe LS; Beaudoin JG; Morehouse DD
    N Engl J Med; 1972 Dec; 287(24):1215-8. PubMed ID: 4563677
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in Fabry's disease.
    Krivit W; Desnick RJ; Mapes C; Anderson RL; Sweeley CC
    Trans Assoc Am Physicians; 1970; 83():121-32. PubMed ID: 4928424
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemistry of glycosphingolipids Fabry's disease.
    Sweeley CC; Snyder PD; Griffin CE
    Chem Phys Lipids; 1970 Aug; 4(3):393-408. PubMed ID: 5511749
    [No Abstract]   [Full Text] [Related]  

  • 10. Correction of the enzymic defect in cultured fibroblasts from patients with Fabry's disease: treatment with purified alpha-galactosidase from ficin.
    Dawson G; Matalon R; Li YT
    Pediatr Res; 1973 Aug; 7(8):684-90. PubMed ID: 4732107
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal transplantation in Fabry's disease.
    Peters PC; Leeber D; Hull AR; Philippart M
    Trans Am Assoc Genitourin Surg; 1972; 64():36-8. PubMed ID: 4569857
    [No Abstract]   [Full Text] [Related]  

  • 12. Ceramide trihexosidosis (fabry's disease) without skin lesions.
    Clarke JT; Knaack J; Crawhall JC; Wolfe LS
    N Engl J Med; 1971 Feb; 284(5):233-5. PubMed ID: 5539345
    [No Abstract]   [Full Text] [Related]  

  • 13. Fabry's disease (ceramide trihexosidase deficiency): diagnostic confirmation by analysis of dental pulp.
    Desnick SJ; Witkop CJ; Krivit W; Thies JK; Desnick RJ
    Arch Oral Biol; 1972 Oct; 17(10):1473-9. PubMed ID: 4507778
    [No Abstract]   [Full Text] [Related]  

  • 14. The biochemical abnormalities in Fabry's disease.
    Kint JA; Dacremont G
    Arch Int Physiol Biochim; 1970 Feb; 78(1):169-71. PubMed ID: 4100872
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversal of an inborn sphingolipidosis (Fabry's disease) by kidney transplantation.
    Philippart M; Franklin SS; Gordon A
    Ann Intern Med; 1972 Aug; 77(2):195-200. PubMed ID: 4565790
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Enhancement of enzymatic activity in Fabry's disease.
    Christensen E
    N Engl J Med; 1974 Mar; 290(11):629-30. PubMed ID: 4204696
    [No Abstract]   [Full Text] [Related]  

  • 17. Absence of cross-reactive antigen in Fabry's disease.
    Beutler E; Kuhl W
    N Engl J Med; 1973 Sep; 289(13):694-5. PubMed ID: 4199465
    [No Abstract]   [Full Text] [Related]  

  • 18. Replacement therapy for inherited enzyme deficiency. Use of purified ceramidetrihexosidase in Fabry's disease.
    Brady RO; Tallman JF; Johnson WG; Gal AE; Leahy WR; Quirk JM; Dekaban AS
    N Engl J Med; 1973 Jul; 289(1):9-14. PubMed ID: 4196713
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of a blood group B glycolipid, accumulating in the pancreas of a patient with Fabry's disease.
    Wherrett JR; Hakomori SI
    J Biol Chem; 1973 May; 248(9):3046-51. PubMed ID: 4735571
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of Fabry's disease: correction of the enzymatic deficiency by renal transplantation.
    Desnick RJ; Allen KY; Simmons RL; Najarian JS; Krivit W
    J Lab Clin Med; 1971 Dec; 78(6):989-90. PubMed ID: 4943510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.